Immunocore Holdings plc (FRA:6YG)
Germany · Delayed Price · Currency is EUR 29.00
-1.00 (-3.33%)
Last updated: Jul 28, 2026, 6:00 PM CET
Immunocore Holdings Market Cap
Immunocore Holdings has a market cap or net worth of €1.51 billion as of July 28, 2026. Its market cap has increased by 0.32% in one year.
Market Cap
1.51B
Enterprise Value
1.15B
Revenue
358.03M
Ranking
n/a
PE Ratio
n/a
Stock Price
€29.00
ChartMarket Cap Chart
Since February 5, 2021, Immunocore Holdings's market cap has increased from 1.49B to 1.51B, an increase of 1.14%. That is a compound annual growth rate of 0.21%.
| Date | Market Cap | % Change |
|---|---|---|
| Jul 27, 2026 | 1.51B | 1.09% |
| Dec 31, 2025 | 1.49B | 4.78% |
| Dec 31, 2024 | 1.43B | -53.35% |
| Dec 29, 2023 | 3.06B | 19.45% |
| Dec 30, 2022 | 2.56B | 93.80% |
| Dec 31, 2021 | 1.32B | -11.59% |
| Feb 5, 2021 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Biotest GmbH & Co. KGaA | 1.31B |
| Novogenia AG | 80.40M |
| 2invest AG | 44.52M |
| Biomark Diagnostics | 34.07M |
| Vidac Pharma Holding | 24.63M |
| co.don AG | 427.57K |
| Paion AG | 392.35K |
| bioXXmed AG | 225.65K |